GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Cibus Inc.
Cibus is a company developing non-GMO plant breeding technologies. Its stock price is a venture bet on the future of agriculture. The chart reflects both its enormous potential and the long road to commercialization and regulatory approval.
Share prices of companies in the market segment - Agricultural technology
Cibus is an agricultural biotechnology company that has developed precision gene editing technology to create new non-GMO crop varieties. We've classified it in the "Agricultural Technology" segment. The graph below shows the overall dynamics in the agritech sector, where genetics is helping to create more resilient plants.
Broad Market Index - GURU.Markets
Cibus is an agritech company that uses advanced breeding methods to create seeds with improved traits, such as herbicide resistance. Its innovations make it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how Cibus compares to it.
Change in the price of a company, segment, and market as a whole per day
CBUS - Daily change in the company's share price Cibus Inc.
Cibus, Inc.'s daily stock price fluctuations reflect volatility in the agtech sector. The metric demonstrates sensitivity to news regarding the development and commercialization of its herbicide-tolerant GMO crops, providing a valuable element for analysis.
Daily change in the price of a set of shares in a market segment - Agricultural technology
Cibus, Inc.'s daily stock price fluctuations reflect volatility in the agtech sector. The metric demonstrates sensitivity to news regarding the development and commercialization of its herbicide-tolerant GMO crops, providing a valuable element for analysis.
Daily change in the price of a broad market stock, index - GURU.Markets
Cibus is a biotech company that uses gene editing to create new, more resilient crop varieties. Its success is changing the future of farming. Cibus's stock price fluctuations reflect progress in agritech, and this innovative momentum contributes to the overall market dynamics depicted in the chart.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Cibus Inc.
Cibus, Inc.'s year-to-date performance is a story about the application of gene editing technology in agriculture. Its 12-month market cap depends on progress in the development and commercialization of its herbicide-tolerant rapeseed and rice varieties, which could offer farmers a more efficient and environmentally friendly alternative to traditional GMOs.
Annual dynamics of market capitalization of the market segment - Agricultural technology
Cibus, Inc. is an agritech company using advanced gene editing technologies to create new plant varieties. Its stock price is extremely volatile, reflecting investor confidence in its breakthrough potential and ability to commercialize its green technology.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Cibus, with its gene-editing technology for agriculture, is a bet on the future of agriculture. Its stock price isn't tied to the economy, but rather to its scientific breakthroughs and ability to commercialize its technology. The chart tells the story of how innovation is addressing food security.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Cibus Inc.
Cibus is an agritech company using gene editing technologies to improve agricultural crops. Its monthly performance reflects progress in the development and commercialization of its hybrids. News of partnerships and regulatory approvals are key drivers.
Monthly dynamics of market capitalization of the market segment - Agricultural technology
Cibus is an agricultural technology company that uses advanced gene editing techniques to create seeds with improved traits without resorting to GMOs. Its success depends on farmers adopting its technology. The agtech sector graph reflects the growing demand for innovations to improve crop yields and agricultural sustainability.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Cibus is a company using gene editing technologies to improve agricultural crops. It is betting on a revolution in agritech. Cibus's stock performance is loosely tied to the market and is driven by scientific breakthroughs, commercialization approvals, and partnerships with major agricultural holdings.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Cibus Inc.
Cibus, an agtech company developing non-GMO gene editing methods for plants, has a weekly stock price that mirrors trends in agriculture. News of partnerships with seed companies and regulatory approvals drive highly volatile short-term trends.
Weekly dynamics of market capitalization of the market segment - Agricultural technology
Cibus uses cutting-edge gene editing technologies to improve crops. Its business straddles the intersection of biotech and agriculture. The chart below shows how the market perceives its innovative potential compared to the traditional agricultural sector, reflecting trends toward sustainable agriculture.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Cibus uses gene-editing technologies for agriculture. Its shares are a bet on future technologies. The chart shows that CBUS's performance is largely uncorrelated with the market, driven by development news and regulatory approvals.
Market capitalization of the company, segment and market as a whole
CBUS - Market capitalization of the company Cibus Inc.
The Cibus chart is a financial map of genetic engineering in agriculture. The market cap of this company, which uses gene editing technologies to create new non-GMO plant varieties, reflects faith in its platform. Its momentum reflects a bet that its technology will enable the creation of more productive and sustainable crops.
CBUS - Share of the company's market capitalization Cibus Inc. within the market segment - Agricultural technology
Cibus's stake in the agritech sector is a bet on the future of agriculture. The company uses cutting-edge gene editing technologies to create new, non-GMO crop varieties. Its market share reflects the potential of this breakthrough and sustainable technology.
Market capitalization of the market segment - Agricultural technology
Cibus is a company that uses advanced breeding technologies to create new traits in plants. The chart below shows the total market capitalization of the entire agritech sector. Its dynamics reflect the need for more sustainable and productive agriculture.
Market capitalization of all companies included in a broad market index - GURU.Markets
Cibus is an agritech company that uses gene editing technologies to create new crop varieties. Its market capitalization is a bet on breakthroughs in breeding. The chart below shows the economic weight of companies changing the way we grow food.
Book value capitalization of the company, segment and market as a whole
CBUS - Book value capitalization of the company Cibus Inc.
Cibus, an agritech company, derives its book value from its laboratories and R&D equipment. The chart below shows the material base for its cutting-edge plant gene editing technology. Growth there represents an investment in science that could transform agriculture.
CBUS - Share of the company's book capitalization Cibus Inc. within the market segment - Agricultural technology
Cibus is a company using gene editing technologies to improve agricultural crops. Its value lies in its scientific platform. The share of tangible assets chart will reflect its focus on R&D, where its main assets are laboratories and greenhouses.
Market segment balance sheet capitalization - Agricultural technology
Cibus is an agritech company that uses gene editing. Its assets are not giant fields, but cutting-edge laboratories and greenhouses. This is capital-intensive R&D. The chart illustrates how dependent the entire agritech sector is on investments in innovation backed by physical assets.
Book value of all companies included in the broad market index - GURU.Markets
Cibus's assets include intellectual property in a unique plant gene editing technology that enables the creation of new non-GMO varieties. The book value reflects the capital invested in this breakthrough agricultural technology, which has the potential to increase crop yields and sustainability.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Cibus Inc.
Cibus is a company that uses gene editing technology to create new traits in crop seeds. Its value lies in its platform, not its fields. The chart shows how investors value its ability to create more productive and resilient crops without the use of traditional GMOs.
Market to book capitalization ratio in a market segment - Agricultural technology
Cibus is an agritech company that uses gene editing technologies to improve crops. Its value lies in its unique scientific platform, not in its fields. The chart shows the enormous premium the market is paying for its potential to revolutionize agriculture.
Market to book capitalization ratio for the market as a whole
Cibus is a company using cutting-edge gene editing technologies to create more productive and resilient seeds. The chart shows how the market values โโthis agtech innovation. The company's market capitalization reflects its bet that its technology will become a new standard in plant breeding, potentially revolutionizing agriculture.
Debts of the company, segment and market as a whole
CBUS - Company debts Cibus Inc.
Cibus is an agricultural technology company developing gene editing technology to improve crops. This process requires extensive and capital-intensive research. This chart shows the company's funding process for its innovative agtech platform.
Market segment debts - Agricultural technology
Cibus is an agritech company that uses gene editing technologies to create new non-GMO crop varieties. This is a breakthrough technology. The chart shows the financial standards for the biotech sector, against which Cibus is raising capital for its long-term research and navigating the complex regulatory landscape.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Cibus Inc.
Cibus is an agritech company developing gene editing technologies to create new crop varieties. This cutting-edge science requires significant, long-term investment. This chart shows Cibus's reliance on debt to finance its R&D, a direct indicator of its financial risk.
Market segment debt to market segment book capitalization - Agricultural technology
Cibus's application of genetic engineering to agriculture to create more resilient crops is at the forefront of agritech. This chart shows the sector's debt burden. It allows one to assess how capital-intensive this technology is and how the company finances its long-term research compared to giants like Bayer (Monsanto) or Corteva.
Debt to book value of all companies in the market
Cibus is a plant breeding company using advanced gene editing technologies. Agritech is a knowledge-intensive industry. The chart shows how their debt-based strategy for funding research and bringing new plant varieties to market compares to traditional agriculture.
P/E of the company, segment and market as a whole
P/E - Cibus Inc.
This chart for Cibus, Inc., a plant breeding company using advanced gene editing technologies, shows its market valuation. The metric reflects investors' confidence in the company's ability to develop new crop varieties that are resistant to diseases and herbicides.
P/E of the market segment - Agricultural technology
This chart shows the average valuation for the agtech sector in which Cibus operates. This metric reflects investor confidence in technological breakthroughs in agriculture. It serves as a benchmark for understanding how the market views the potential of Cibus's gene editing technology relative to the broader industry.
P/E of the market as a whole
Cibus is an agricultural technology company that uses advanced gene editing techniques to create new crop varieties with desirable traits, such as disease resistance. This chart reflects interest in the innovation. It helps understand whether the market believes Cibus's technology can accelerate plant breeding and how it compares to traditional GMOs.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Cibus Inc.
Cibus is an agricultural technology company that uses advanced breeding methods to develop new traits in plants, such as herbicide resistance, without the use of GMO technology. The company's future depends on the adoption of its approach. This chart shows how investors view its innovation platform and the commercial potential of its products for farmers.
Future (projected) P/E of the market segment - Agricultural technology
Cibus is an agricultural technology company that uses advanced (non-GMO) breeding methods to create new crop varieties with improved traits. This chart shows industry expectations, helping to understand how the market views this innovative agtech platform.
Future (projected) P/E of the market as a whole
Cibus is an agricultural technology company that uses advanced gene editing techniques to create new crop varieties with improved traits. This overall expectations chart reflects the company's belief in agritech. Market optimism and the need to improve yields and agricultural sustainability are driving demand for innovative solutions like those offered by Cibus.
Profit of the company, segment and market as a whole
Company profit Cibus Inc.
Cibus is a company that breeds agricultural crops using advanced gene editing technologies. This chart shows the financial health of this agtech innovator. Profits will depend on the successful commercialization of plant varieties with improved traits, such as herbicide or disease resistance.
Profit of companies in the market segment - Agricultural technology
CTRL Group Limited likely operates in the media or advertising technology sector. Its profitability will depend on its specific business model and competitive environment. This chart reflects general trends in the media sector, where digitalization and the competition for audience attention and advertising budgets are key drivers of profitability.
Overall market profit
Cibus is a plant breeding company using advanced gene editing technologies. Unlike GMOs, its approach allows for targeted changes without introducing foreign genes. The company's success depends on the implementation of its technologies, which can improve the yield and sustainability of agricultural crops.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Cibus Inc.
Cibus is an agricultural technology company that uses advanced (non-GMO) breeding methods to create new crop varieties with improved traits. Profit projections depend on the commercialization of these varieties. This chart shows analyst expectations for the future of agriculture and the potential of Cibus's technology.
Future (predicted) profit of companies in the market segment - Agricultural technology
Cibus is a plant breeding company using advanced gene editing technologies. The company develops new crop varieties with improved traits, such as herbicide resistance. This chart shows profitability forecasts for the agricultural sector, reflecting how biotechnology is changing agriculture.
Future (predicted) profit of the market as a whole
Cibus is a plant breeding company using advanced gene editing technologies to improve yields and sustainability. Demand for its technology depends on agricultural needs. This profit forecast chart reflects the overall state of the economy, which impacts food prices and farmers' willingness to invest in innovation.
P/S of the company, segment and market as a whole
P/S - Cibus Inc.
Cibus is an agricultural technology company that uses advanced (non-GMO) breeding methods to create new crop varieties with improved traits, such as herbicide resistance. The chart reflects the evaluation of its innovative platform, which has the potential to improve agricultural yields and sustainability.
P/S market segment - Agricultural technology
Cibus, Inc. is an agricultural technology company that has developed a cutting-edge gene-editing platform that enables the creation of new traits in plants, such as herbicide and disease resistance. This chart shows the average valuation in the sector, allowing one to assess how the market values โโCibus's breakthrough technology in agtech.
P/S of the market as a whole
Cibus is an agricultural technology company that uses gene editing technology to create new crop varieties with improved traits. This chart, showing average valuations, clearly highlights the gap between traditional businesses and companies developing breakthrough agricultural technologies.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Cibus Inc.
Cibus is an agricultural technology company that uses advanced gene editing techniques to create new traits in seeds. This chart reflects investors' confidence in the future commercial success of its platform. The valuation is based on expected revenues from technology licensing and sales of seeds with improved traits, such as herbicide resistance.
Future (projected) P/S of the market segment - Agricultural technology
Cibus, Inc. is an agricultural technology company that uses gene editing technologies to develop new crop varieties with improved traits, such as herbicide resistance. The chart shows how the market estimates Cibus's future revenue, reflecting the potential of its platform to create more sustainable agriculture.
Future (projected) P/S of the market as a whole
This graph reflects the belief that technology can make agriculture more precise and sustainable. Cibus, using its gene-editing technologies, creates seed hybrids with improved traits, such as herbicide and disease resistance. Their innovations demonstrate how biotechnology can contribute to increased crop yields and food security.
Sales of the company, segment and market as a whole
Company sales Cibus Inc.
Cibus uses advanced gene editing technologies to develop new crop varieties. Currently in the commercialization stage, the company generates revenue through sales of enhanced seeds and licensing agreements. This chart shows the initial steps toward monetizing its breakthrough agricultural technologies.
Sales of companies in the market segment - Agricultural technology
Cibus is a plant breeding company using advanced gene editing technologies. This allows the creation of new varieties with desired traits, such as herbicide resistance. This chart shows the total revenue in the agtech sector. It reflects the future of agriculture, where precision breeding will improve crop yields and resilience.
Overall market sales
Cibus is an agricultural technology company that uses advanced breeding methods to create seeds with desirable traits (such as herbicide resistance) without the use of GMOs. Success depends on the adoption of its technology by farmers. This graph of overall economic activity reflects the state of the agricultural sector and its willingness to invest in new technologies.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Cibus Inc.
Cibus is an agricultural technology company that uses advanced (non-GMO) breeding methods to create new crop varieties with improved traits, such as herbicide resistance. The chart shows analyst forecasts for the commercialization of its innovative seeds.
Future (projected) sales of companies in the market segment - Agricultural technology
Cibus is an agricultural technology company that has developed a platform for precision gene editing of plants without inserting foreign DNA. This allows for the creation of higher-yielding and more resilient crops. This chart shows projected revenues for the entire agritech sector, reflecting overall expectations for the market for innovations in plant breeding and agriculture.
Future (projected) sales of the market as a whole
Cibus is an agritech company developing gene editing technology to create new non-GMO crop varieties. Its success depends on the commercialization of its technology. This trend in overall economic activity impacts the agricultural sector and its willingness to embrace innovation to improve yields and sustainability.
Marginality of the company, segment and market as a whole
Company marginality Cibus Inc.
Cibus is an agricultural technology company that develops new crop varieties using precision gene editing. This metric reflects the financial progress of agritech innovations, demonstrating how close the company is to converting revenue from its technologies into sustainable net profit.
Market segment marginality - Agricultural technology
Cibus is an agritech company that uses gene editing technology to create new traits in seeds, such as herbicide resistance. Profitability depends on the commercialization of these innovative seeds. This metric reflects the company's operational structure compared to traditional seed and agrochemical producers.
Market marginality as a whole
Cibus is an agricultural technology company that has developed cutting-edge gene editing technology to create new crop varieties with desired traits (such as herbicide resistance). This overall profitability curve affects them through the willingness of farmers and agricultural holdings to pay for innovative seeds that increase yields.
Employees in the company, segment and market as a whole
Number of employees in the company Cibus Inc.
Cibus is an agritech company that uses advanced gene editing techniques to improve crops. Its core asset is science. This chart shows the size of its team of scientists and breeders. Growth here reflects investments in developing new plant traits, such as herbicide and disease resistance.
Share of the company's employees Cibus Inc. within the market segment - Agricultural technology
Cibus is a company that uses cutting-edge gene editing technologies to create new traits in plants. This chart shows the concentration of exceptional molecular biologists and plant breeders. The proportion of such talent reflects its role as a pioneer in creating more resilient and productive crops.
Number of employees in the market segment - Agricultural technology
Cibus, Inc. is an agricultural technology company that uses advanced gene editing techniques to create new crop varieties with improved traits. This chart shows overall employment in the agtech sector and illustrates how Cibus strives to improve crop yields and resilience without the use of GMO technologies.
Number of employees in the market as a whole
Cibus is an agricultural technology company that has developed cutting-edge gene editing technology (without inserting foreign genes) to create new plant varieties. This is a revolution in plant breeding. This employment chart also reflects the growth of the AgTech sector, where such companies are creating jobs for geneticists, agronomists, and molecular biologists.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Cibus Inc. (CBUS)
Cibus, Inc. is an agricultural technology company that uses advanced gene editing techniques to create new plant varieties. This chart shows how the market values โโthis breakthrough technology in the agricultural sector. The high market capitalization per employee suggests that investors see enormous potential in its intellectual property and patents.
Market capitalization per employee (in thousands of dollars) in the market segment - Agricultural technology
Cibus is a plant breeding company using cutting-edge gene editing technologies. It's a science-based agritech business. This metric reflects how highly the market values โโtheir platform for creating new varieties. Their high market capitalization per employee reflects their belief that their technologies will revolutionize agriculture.
Market capitalization per employee (in thousands of dollars) for the overall market
Cibus, Inc. is an agricultural biotechnology company that uses gene editing technologies to improve crops. Its valuation is based on the potential of its platform. The high valuation per employee reflects investors' belief that its technology can create more productive and resilient plants.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Cibus Inc. (CBUS)
Cibus (CBUS) is an agtech company. They use their proprietary gene-editing technology (non-GMO) to create new traits in seeds (for example, herbicide resistance). It's an R&D company. This chart shows the net loss (investment in research) per biologist.
Profit per employee (in thousands of dollars) in the market segment - Agricultural technology
Cibus is an agritech company using gene editing to create new crop varieties. At the R&D stage, this metric isn't key. The schedule sets the bar. Cibus's goal is to develop traits (such as herbicide resistance) that they will license to seed giants, earning royalties with a high profit per employee.
Profit per employee (in thousands of dollars) for the market as a whole
Cibus (CBUS) is an agritech company. They use gene-editing technology (non-GMO) to create improved seeds, such as rice or canola, that are herbicide-resistant. This metric reflects their R&D status. Their profit per employee is negative until their seeds reach the mass market.
Sales to employees of the company, segment and market as a whole
Sales per company employee Cibus Inc. (CBUS)
For Cibus, a plant breeding company using advanced gene editing technologies, this graph reflects the commercialization of its innovations. Growth in revenue per employee will depend on the successful launch of new crop varieties with improved characteristics.
Sales per employee in the market segment - Agricultural technology
Cibus is an agritech company that uses gene editing technology (RTDSโข) to create new traits in seeds (e.g., herbicide resistance). This is R&D. This metric reflects the average revenue per employee in the segment. It helps evaluate how productive their R&D team is in commercializing their technologies compared to other agritech companies.
Sales per employee for the market as a whole
Cibus (CBUS) is an agritech company developing precision gene editing technology (non-GMO) to create improved crop varieties. This metric tracks their progress from R&D to commercialization. An increase in revenue (royalties) per employee (scientist) will signal the market entry of their "edited" seeds.
Short shares by company, segment and market as a whole
Shares shorted by company Cibus Inc. (CBUS)
Cibus is a plant breeding company using gene-editing technology (CRISPR). It's a speculative bet on agriculture. This chart reflects investors' bets that its technology will face regulatory hurdles or that its gene-edited seeds will fail to achieve commercial success.
Shares shorted by market segment - Agricultural technology
Cibus (CBUS) is an agtech company that uses gene editing (non-GMO) to create new traits in crops. This chart shows the aggregate short position in the agtech sector. It reflects investor skepticism regarding the commercialization timeline and regulatory barriers for gene-edited products.
Shares shorted by the overall market
Cibus (CBUS) is an agritech R&D company working with gene editing. It's a speculative bet on the "food of the future." When this market fear indicator rises, investors are unwilling to fund "science." They're selling off "concept stocks" en masse without profit, fearing CBUS will run out of cash.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Cibus Inc. (CBUS)
For Cibus, this chart is an indicator of faith in "green" genetic engineering. The company uses gene-editing technology (not GMOs) to improve crops (for example, herbicide resistance). Positive field trial data or regulatory approval lead to "overheating" (above 70). Doubts about the platform's effectiveness or slow adoption lead to "oversold" conditions.
RSI 14 Market Segment - Agricultural technology
Cibus (CBUS) is "GMO" 2.0. They're *not* Monsanto, but an "agri-biotech" that uses *gene editing* (non-GMO) to *improve* seeds (canola, rice). The "Agricultural Technology" sector thrives on hype. RSI_14_Seg shows the "temperature" of the *entire* industry. It helps us understand: is CBUS's growth a niche or a part of the *general* hype?
RSI 14 for the overall market
Cibus (CBUS), an agritech company, sees this chart as a sign of appetite for the "future." In a euphoric mood, investors are ready to fund R&D for "new" agriculture. In a panic, they flee unprofitable R&D projects. However, panic in food markets (rising prices) could, on the contrary, stimulate demand for its technologies.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast CBUS (Cibus Inc.)
Cibus is an agritech company that uses gene-editing technology (non-GMO) to create improved seeds (for example, herbicide-resistant ones). This chart shows the speculative average target price from analysts, based on their assessment of the commercial potential of this R&D platform in agriculture.
The difference between the consensus estimate and the actual stock price CBUS (Cibus Inc.)
Cibus (CBUS) is an agritech company that uses precision gene editing (non-GMO) to create more resilient seeds (like canola). This chart is a barometer of their R&D. It measures the gap between the price and the consensus target, reflecting the high, yet speculative, potential analysts see in their "green" genetics.
Analyst consensus forecast for stock prices by market segment - Agricultural technology
Cibus (CBUS) is an agtech company that uses gene editing (non-GMO) to create improved seeds (e.g., herbicide-tolerant canola). This chart shows general expectations for the agtech sector. It reflects whether experts believe in the commercial success and adoption of gene-edited crops.
Analysts' consensus forecast for the overall market share price
Cibus (CBUS) is an agritech company. They use gene editing technology (non-GMO) to create new traits in seeds (for example, herbicide resistance). This chart shows the overall risk appetite. For Cibus, operating in a "green" but speculative field, overall market optimism is important for funding the long process of seed development and commercialization.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Cibus Inc.
Cibus is a gene editing solution for farmers. Unlike GMOs, they use their non-transgenic technology (RTDS) to edit the genes of seeds (such as canola) to make them more tolerant to herbicides or drought. This graph is a summary of their R&D, reflecting their progress toward commercialization and their ability to compete with the Big Four agrochemicals.
AKIMA Market Segment Index - Agricultural technology
Cibus, Inc. (CBUS) is an agricultural technology (AgTech) company that uses advanced gene editing (non-GMO) to create new traits in seeds. The chart represents the segment average, allowing investors to assess how Cibus's breakthrough technology compares in terms of effectiveness and potential compared to other AgTech companies.
The AKIM Index for the overall market
Cibus is an agritech company using gene editing to create sustainable and productive (non-GMO) crops. This chart, which reflects the market average, provides context. It helps us assess how this innovative seed-changing story fits into the context of overall macroeconomic trends and food demand.